SHARE PRICE > View All Stock Detailed Share Information Latest News Molecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM 2023 Annual Meeting Molecular Partners Reports H1 2023 Corporate Highlights and Financials Molecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at SNMMI 2023 > View All News All News Upcoming Events More events are coming soon. > View All Events All Events Latest Presentation September 21, 2023 Corporate Presentation - September 2023 August 24, 2023 H1 2023 Results Presentation May 26, 2023 RBC Healthcare Conference Presentation > View All Presentations All Presentations Latest Financial Documents August 24, 2023 H1 2023 Business Update and Financial Statements April 19, 2023 Molecular Partners statement regarding Passive Foreign Investment Company status March 9, 2023 Annual Report FY2022 > View All Reports All Annual Report Seth Lewis, SVP Investor Relations and Strategy Contact Seth STAY INFORMED Subscribe to email alerts of your choosing SUBSCRIBE Institutional investors: REQUEST 1-1 / CALL powered by schedulR
Molecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM 2023 Annual Meeting
